11 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Active TB: • ... Active TB: • ... Treatment: Active ... #ActiveTB #LatentTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Active TB: • ... Active TB: • ... Treatment: Active ... #ActiveTB #LatentTB
Tuberculosis Testing

LATENT TB
• LTBI is diagnosed when an asymptomatic patient has a positive TST or IGRA
LATENT TB • ... result with no clinical ... used to exclude pulmonary ... #Latent #Active ... #LatentTB #ActiveTB
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Tuberculosis - ... #ActiveTB #RIPE ... #medications #pharmacology ... #Treatment
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
extrapulmonary cases Clinical ... signs/symptoms of active ... pulmonary TB PE ... tissue damage - CXR ... for concomitant pulmonary
Cavitary Lesion with Air-Fluid Level on Chest XRay

70+ year old man with PMH of latent TB
man with PMH of latent ... TB s/p treatment ... Labeled CXR: ... #ChestXRay #Clinical ... #Pulmonary #Radiology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... for active or latent ... HIV-infected persons with clinical ... #TB #IDSA #Prevention ... infections #HIVAIDS #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Multi-Drug Resistant Tuberculosis ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Primairy TB is usually clinically silent.
In 5% of infected individuals the immunity is inadequate and clinically
clinically silent ... active disease ... reactivation of the latent ... On the CXR it is ... #CXR #Tuberculosis
TB
This patient presented first with the CXR on the left.
The findings are:
Widespread ill-defined densities, which are
first with the CXR ... reactivation of a latent ... #Clinical #Radiology ... #CXR #Tuberculosis ... #TB #Active #SecondaryTB